Hongna Lai

Most-cited papers

1. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

   Qianfeng Shi, Yu-Dong Li, Shun-Ying Li, Liang Jin +11 more

   2020Nature Communications166 citations Open access

   Semantic Scholar

   Save

2. Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

   Zijie Cai, Jing-Ru Wang, Yu-Dong Li, Qianfeng Shi +13 more

   2022Science China Life Sciences104 citations

   Semantic Scholar

   Save

3. Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

   Shun-Ying Li, Hongna Lai, Jieqiong Liu, Yu-Jie Liu +17 more

   2020JCO Precision Oncology64 citations Open access

   Semantic Scholar

   Save

4. Discovery of CCL18 antagonist blocking breast cancer metastasis

   Yu-Jie Liu, Huaqin Zheng, Qian Li, Shun-Ying Li +4 more

   2019Clinical and Experimental Metastasis26 citations

   Semantic Scholar

   Save

5. Long non‐coding RNA CRALA is associated with poor response to chemotherapy in primary breast cancer

   Yu-Dong Li, B. Wang, Hongna Lai, Shun-Ying Li +4 more

   2017Thoracic Cancer19 citations Open access

   Semantic Scholar

   Save

6. LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP

   Hongna Lai, Rui Wang, Shun-Ying Li, Qianfeng Shi +3 more

   2019Science China Life Sciences18 citations

   Semantic Scholar

   Save

7. HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer

   Mengdi Zhu, Nianqiu Liu, Jin-Na Lin, Jing-Ru Wang +2 more

   2022Oncology Letters14 citations Open access

   Semantic Scholar

   Save

8. Non‐invasive analysis of tumor mutation profiles and druggable mutations by sequencing of cell free DNA of Chinese metastatic breast cancer patients

   Shun-Ying Li, Xiaobao Wang, Yuquan Li, Hongna Lai +2 more

   2019Thoracic Cancer11 citations Open access

   Semantic Scholar

   Save

9. Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis

   Hongna Lai, Wei-Zhong Jiang, Jian-Li Zhao, Xiao-xiao Dinglin +4 more

   2021Journal of Cancer6 citations Open access

   Semantic Scholar

   Save

10. Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer

    Mengdi Zhu, Jin-Na Lin, Hao-Han Liu, Jing-Ru Wang +4 more

    2025Cancer Cell International2 citations Open access

    Semantic Scholar

    Save

11. Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple‐Negative Breast Cancer: Real‐World Outcomes From a Retrospective Cohort Study

    Yu-Dong Li, Jin-Na Lin, Mengdi Zhu, Zijie Cai +6 more

    2026MedComm0 citations Open access

    Semantic Scholar

    Save

12. Circulating tumor DNA in monitoring the dynamic changes of tumor burden during treatment of metastatic breast cancer

    Shun-Ying Li, Yi-Chao Fang, Hongna Lai, Yu-Dong Li

    20180 citations

    Semantic Scholar

    Save